Patents by Inventor Hans B. Andreasen

Hans B. Andreasen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IRON COMPLEX COMPOUNDS FOR THERAPUTIC USE
    Publication number: 20220041640
    Abstract: The present invention relates to iron complex compounds for therapeutic use which are low in arsenic, chromium, lead, cadmium, mercury and/or aluminum, compositions thereof and processes for preparing said iron complex compounds.
    Type: Application
    Filed: August 18, 2021
    Publication date: February 10, 2022
    Inventors: Tobias S. CHRISTENSEN, Hans B. ANDREASEN
  • Iron complex compounds for therapeutic use
    Patent number: 11111261
    Abstract: The present invention relates to iron complex compounds for therapeutic use which are low in arsenic, chromium, lead, cadmium, mercury and/or aluminum, compositions thereof and processes for preparing said iron complex compounds.
    Type: Grant
    Filed: February 13, 2019
    Date of Patent: September 7, 2021
    Assignee: Pharmacosmos Holding A/S
    Inventors: Tobias S. Christensen, Hans B. Andreasen
  • IRON COMPLEX COMPOUNDS FOR THERAPEUTIC USE
    Publication number: 20190177353
    Abstract: The present invention relates to iron complex compounds for therapeutic use which are low in arsenic, chromium, lead, cadmium, mercury and/or aluminum, compositions thereof and processes for preparing said iron complex compounds.
    Type: Application
    Filed: February 13, 2019
    Publication date: June 13, 2019
    Inventors: Tobias S. CHRISTENSEN, Hans B. ANDREASEN
  • Composition for removing or inactivating harmful components in blood or other extracellular body fluids
    Patent number: 5514668
    Abstract: A composition for removing or inactivating harmful components including virus from blood or other extracellular liquids comprises a crown ether compound substituted on a polysaccharide, preferably dextran. The composition may be soluble in water, preferably for intraveneous application, or insoluble for extracorporeal application.
    Type: Grant
    Filed: March 4, 1994
    Date of Patent: May 7, 1996
    Assignee: A/S af 18. juni 1990
    Inventors: Henry M. Christensen, Hans B. Andreasen
  • Composition for removing or inactivating harmful components in blood or other extracellular body fluids
    Patent number: 5314878
    Abstract: A composition for removing or inactivating harmful components including virus from blood or other extracellular liquids comprises a crownether compound substituted on a polysaccharide, preferably dextrane. The composition may be soluble in water, preferably for intraveneous application, or insoluble for extracorporeal application.
    Type: Grant
    Filed: December 13, 1991
    Date of Patent: May 24, 1994
    Assignee: A/S af 18. juni 1990
    Inventors: Henry M. Christensen, Hans B. Andreasen